{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:48:23Z","timestamp":1791416903680,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s10549-012-2251-x","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T07:04:46Z","timestamp":1349075086000},"page":"479-486","source":"Crossref","is-referenced-by-count":43,"title":["A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900\u00a0mg versus placebo for anxiety symptoms in breast cancer survivors"],"prefix":"10.1007","volume":"136","author":[{"given":"Jill E.","family":"Lavigne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Heckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Palesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Kirshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Amos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Mustian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"issue":"6","key":"2251_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.amjmed.2009.09.042","volume":"123","author":"P Chalasani","year":"2010","unstructured":"Chalasani P, Downey L, Stopeck AT (2010) Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med 123(6):489\u2013495","journal-title":"Am J Med"},{"issue":"31","key":"2251_CR2","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1200\/JCO.2006.08.8575","volume":"24","author":"J Khatcheressian","year":"2006","unstructured":"Khatcheressian J, Wolff A, Smith T et al (2006) American Society of Clinical Oncology 2006 update of breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091\u20135097","journal-title":"J Clin Oncol"},{"key":"2251_CR3","doi-asserted-by":"crossref","unstructured":"Lavigne JE, Griggs JJ, Tu XM, Lerner DJ. Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv. 2008 Dec;2(4):296\u2013302","DOI":"10.1007\/s11764-008-0072-z"},{"key":"2251_CR4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.psy.51.2.112","volume":"51","author":"K Hartl","year":"2010","unstructured":"Hartl K, Schennach R, Muller M, Engel J, Reinecker H, Sommer H, Friese K (2010) Quality of life, anxiety, and oncological factors: a follow-up study of breast cancer patients. Psychosomatics 51:112\u2013123","journal-title":"Psychosomatics"},{"issue":"3","key":"2251_CR5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00127-009-0068-7","volume":"45","author":"M Vahdaninia","year":"2010","unstructured":"Vahdaninia M, Omidvari S, Montazeri A (2010) What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 45(3):355\u2013361","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"36","key":"2251_CR6","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1200\/JCO.2009.22.5151","volume":"27","author":"J Armes","year":"2009","unstructured":"Armes J, Crowe M, Colbourne L et al (2009) Patients\u2019 supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 27(36):6172\u20136179","journal-title":"J Clin Oncol"},{"key":"2251_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Lowe B (2007) Anxiety disorders in primary care: prevalence, impairment, comorbidity and detection. Ann Intern Med 146:317\u2013325","journal-title":"Ann Intern Med"},{"key":"2251_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4088\/JCP.8125tx4c","volume":"71","author":"LN Ravindran","year":"2010","unstructured":"Ravindran LN, Stein MB (2010) The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry 71:7","journal-title":"J Clin Psychiatry"},{"key":"2251_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000117423.05703.e7","volume":"24","author":"AC Pande","year":"2004","unstructured":"Pande AC, Feltner DE, Jefferson JW et al (2004) Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled multi-center study. J Clin Psychopharmacol 24:141\u2013149","journal-title":"J Clin Psychopharmacol"},{"key":"2251_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4088\/JCP.v67n0511","volume":"67","author":"SA Montgomery","year":"2006","unstructured":"Montgomery SA, Tobias K, Zornberg GL et al (2006) Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry 67:771\u2013782","journal-title":"J Clin Psychiatry"},{"key":"2251_CR11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMcp060145","volume":"355","author":"FR Scheiner","year":"2006","unstructured":"Scheiner FR (2006) Clinical practice: social anxiety disorder. N Engl J Med 355:1029\u20131036","journal-title":"N Engl J Med"},{"issue":"1","key":"2251_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","volume":"22","author":"CJ Landmark","year":"2008","unstructured":"Landmark CJ (2008) Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 22(1):27\u201347","journal-title":"CNS Drugs"},{"key":"2251_CR13","unstructured":"Jacox A, Carr DB, Payne R, et al. (1994) Management of cancer pain. Clinical practice guideline no. 9. AHCPR publication no. 94-0592. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, Rockville"},{"key":"2251_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpainsymman.2006.11.013","volume":"34","author":"K Keskinbora","year":"2007","unstructured":"Keskinbora K, Pekel EF, Aydinli I (2007) Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manage 34:183\u2013189","journal-title":"J Pain Symptom Manage"},{"key":"2251_CR15","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni A, Zecca E, Bonezzi C et al (2004) Gabapentin for neuropathic cancer pain: a randomized, controlled trial from the gabapentin cancer pain study group. J Clin Oncol 22:2909\u20132917","journal-title":"J Clin Oncol"},{"key":"2251_CR16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jpainsymman.2004.08.014","volume":"29","author":"A Caraceni","year":"2005","unstructured":"Caraceni A, Brunelli C, Martini C et al (2005) Cancer pain assessment in clinical trials. A review of the literature. J Pain Symptom Manage 29:507\u2013519","journal-title":"J Pain Symptom Manage"},{"key":"2251_CR17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1213\/01.ANE.0000180200.11626.8E","volume":"101","author":"A Fassoulaki","year":"2005","unstructured":"Fassoulaki A, Triga A, Melemeni A et al (2005) Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg 101:1427\u20131432","journal-title":"Anesth Analg"},{"key":"2251_CR18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/01.ANE.0000152010.74739.B8","volume":"100","author":"C Menigaux","year":"2005","unstructured":"Menigaux C, Adam F, Guignard B, Sessler DI, Chauvin M (2005) Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg 100:1394\u20131399","journal-title":"Anesth Analg"},{"key":"2251_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-3959(99)00073-1","volume":"82","author":"A Caraceni","year":"1999","unstructured":"Caraceni A, Portenoy RK (1999) A working group of the IASP task force on cancer pain. An international survey of cancer pain characteristics and syndromes. Pain 82:263\u2013274","journal-title":"Pain"},{"key":"2251_CR20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","volume":"366","author":"KJ Pandya","year":"2005","unstructured":"Pandya KJ, Morrow GR, Roscoe JA et al (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial. Lancet 366:818\u2013824","journal-title":"Lancet"},{"key":"2251_CR21","volume-title":"STAI manual for the state-trait anxiety inventory","author":"CD Speilberger","year":"1970","unstructured":"Speilberger CD, Gorsuch RL, Luschene R (1970) STAI manual for the state-trait anxiety inventory. Consulting Psychologists, Palo Alto"},{"key":"2251_CR22","doi-asserted-by":"crossref","first-page":"s3147","DOI":"10.1136\/bmj.a3147","volume":"338","author":"K Beaver","year":"2009","unstructured":"Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A et al (2009) Comparing hospital and telephone follow-up after treatment for breast cancer: randomized equivalence trial. BMJ 338:s3147","journal-title":"BMJ"},{"issue":"17","key":"2251_CR23","first-page":"386","volume":"115","author":"R Bergh Van den","year":"2009","unstructured":"Van den Bergh R, Essink-Bot ML, Roobol MJ et al (2009) Anxiety and distress during active surveillance for early prostate cancer. Cancer 115(17):386\u20133878","journal-title":"Cancer"},{"issue":"2","key":"2251_CR24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jclinepi.2008.03.006","volume":"62","author":"BL Oudsten Den","year":"2009","unstructured":"Den Oudsten BL, Van Heck GL, Van der Steeg AFW, Roukema JA, DeVries J (2009) The WHOQOL-100 has good psychometric properties in breast cancer patients. J Clin Epidemiol 62(2):195\u2013205","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2251_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2354.2007.00902.x","volume":"18","author":"DR Fenlon","year":"2009","unstructured":"Fenlon DR, Corner JL, Haviland J (2009) Menopausal hot flushes after breast cancer. Eur J Cancer Care 18(2):14\u2013148","journal-title":"Eur J Cancer Care"},{"key":"2251_CR26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.104.067959","volume":"311","author":"K Cundy","year":"2004","unstructured":"Cundy K, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, Barrett RW, Gallop MA (2004) XP13512: a novel gabapentin prodrug: II. Improved oral availability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther 311:324\u2013333","journal-title":"J Pharmacol Exp Ther"},{"key":"2251_CR27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ejca.2008.03.022","volume":"48","author":"B Laird","year":"2008","unstructured":"Laird B, Colvin L, Fallon M (2008) Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer 48:1078\u20131082","journal-title":"Eur J Cancer"},{"key":"2251_CR28","unstructured":"Gabapentin. DRUGDEX\u00ae System. Thomson Healthcare. http:\/\/www.thomsonhc.com . Accessed 7 Aug 2012"},{"key":"2251_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000330814","volume":"81","author":"R Vaidya","year":"2011","unstructured":"Vaidya R, Sood R, Karlin N, Jatoi A (2011) Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1000 patients. Oncology 81:9\u201311","journal-title":"Oncology"},{"issue":"4","key":"2251_CR30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.2011.3","volume":"89","author":"L Orriols","year":"2011","unstructured":"Orriols L, Phillip P, Moore N et al (2011) Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther 89(4):595\u2013601","journal-title":"Clin Pharmacol Ther"},{"key":"2251_CR31","first-page":"49","volume":"54","author":"J Cole","year":"1993","unstructured":"Cole J, Kando J (1993) Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. J Clin Psychiatry 54:49\u201363","journal-title":"J Clin Psychiatry"},{"key":"2251_CR32","doi-asserted-by":"crossref","first-page":"s399","DOI":"10.1016\/S0924-977X(99)00051-6","volume":"9","author":"M Lader","year":"1999","unstructured":"Lader M (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 9:s399\u2013s940","journal-title":"Eur Neuropsychopharmacol"},{"key":"2251_CR33","doi-asserted-by":"crossref","first-page":"d1199","DOI":"10.1136\/bmj.d1199","volume":"342","author":"D Baldwin","year":"2011","unstructured":"Baldwin D, Woods R, Lawson R (2011) Efficacy of drug treatments for generalized anxiety disorder: systemic review and meta-analysis. BMJ 342:d1199","journal-title":"BMJ"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2251-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2251-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:34:07Z","timestamp":1559234047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2251-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]}}}